Enveda Biosciences
Translates nature's chemistry into small-molecule therapeutics using AI and metabolomics.
What they do
Enveda Biosciences uses metabolomics and machine learning to map the chemical diversity of plants. By identifying and isolating active small molecules from natural sources, the company creates a proprietary library of novel drug candidates for pharmaceutical development targeting inflammatory and metabolic diseases.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Natural product discovery
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Boulder, USA
- Region
- North America
- Founded
- 2019
- Total funding
- $230M raised
Notable investors: Kinnevik, F-Prime Capital, True Ventures, Premji Invest.